34
https://pubmed.ncbi.nlm.nih.gov/38093354
Mesenchymal stem cells overexpressing interleukin-10 hold promise as a novel therapy for allergic airway inflammation, as demonstrated by their ability to reduce inflammation in both mouse models and human CD4+ T cells.
